Omeprazol Distriquimica (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Distriquimica, is a proton pump inhibitor presented as a oral tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazol Distriquimica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Distriquimica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders.

- Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑associated ulcer prevention: lowers the risk of ulcer development in at‑risk patients.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Abdominal pain or discomfort: transient. - Nausea or vomiting: occasional. - Flatulence: mild. - Constipation: occasional.

Serious or Rare Side Effects: - Clostridioides difficile infection: may present with severe diarrhea. - Acute interstitial nephritis: renal inflammation requiring medical attention. - Hypomagnesemia: low magnesium levels with prolonged use. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions. - Osteoporotic fractures: increased risk with long‑term therapy. - Liver enzyme elevation: may indicate hepatic stress.

When using Omeprazole, consider the following safety measures:

- Assess renal function: adjust use in severe renal impairment. - Evaluate hepatic function: use with caution in moderate to severe liver disease. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Limit duration: avoid unnecessary long‑term use to reduce fracture risk. - Pregnancy and lactation: weigh benefits against potential risks; consult a healthcare professional. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption, loss of antiviral efficacy. - Dasatinib: lowered plasma concentrations, reduced therapeutic effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation parameters. - Phenytoin: decreased serum levels, monitor seizure control. - Methotrexate: increased exposure, especially with high‑dose regimens. - Digoxin: elevated serum concentrations, monitor cardiac status.